Beloxepin

Drug Profile

Beloxepin

Alternative Names: ADL 6906; ORG 4428

Latest Information Update: 15 Dec 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Organon
  • Developer Cubist Pharmaceuticals; Organon
  • Class Analgesics; Antidepressants; Antineoplastics; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Major depressive disorder; Pain

Most Recent Events

  • 15 Dec 2011 Discontinued - Phase-I for Pain in USA (PO)
  • 12 Dec 2011 Adolor Corporation has been acquired and merged into Cubist Pharmaceuticals
  • 11 Nov 2010 Adolor Corporation acquires rights to access data on beloxepin from Organon
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top